Magnetic resonance imaging in multiple sclerosis;Actualités club francophone de la sclérose en plaques imagerie par résonance magnétique et sclérose en plaques

Revue Neurologique

Volumn 158, Issue 10 I, 2002, Pages 1025-1032

  Brochet, B ^a,b   Dousset, V ^b  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; IRON OXIDE;

CONTRAST ENHANCEMENT; DIAGNOSTIC TEST; INFLAMMATION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCLEROSIS; TISSUE INJURY; ANIMAL; BRAIN; HUMAN; MULTIPLE SCLEROSIS; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY SYSTEM; REVIEW; SPINAL CORD;

ANIMALS; BRAIN; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; RESPIRATORY SYSTEM; SPINAL CORD;

EID: 0036807157     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (28)

1. Arnold DL, Wolinsky JS, Matthews PM, Falini A. (1998). The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry, 64 Suppl 1: S94-101.
2. Barkhof F, Filippi M, Miller DH, et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain, 120: 2059-69.
3. Brex PA, Miszkiel KA, O'riordan JI, Plant GT, Moseley IF, Thompson AJ, Miller DH. (2001). Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: The role of a follow up MRI. J Neurol Neurosurg Psychiatry, 70: 390-393.
4. Brochet B, Dousset V. (1999). Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. Neurology, 53: S12-S17.
5. Comi G, Filippi M, Barkhof F, et al. (2001). Effect of early interferon treatment on conversion to definite multiple sclerosis: A randomised study. Lancet, 357: 1576-1582.
6. Dousset V, Grossman RI, Ramer KN, et al. (1992). Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging. Radiology, 182: 483-491.
7. Dousset V, Gayou A, Brochet B, Caille JM. (1998). Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology, 51: 1150-1155.
8. Dousset, V, Delalande, C, Ballarino, L, et al. (1999). In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med, 41: 329-333.
9. Fazekas F, Offenbacher H, Fuchs S, Schmidt R, Niederkorn K, Horner S, Lechner H. (1988). Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology, 38: 1822-1825.
10. Hanemann CO, Kleinschmidt A, Reifenberger G, Freund HJ, Seitz RJ. (1993). Balo's concentric sclerosis followed by MRI and positron emission tomography. Neuroradiology, 35: 578-580.
11. Grassin M, Brochet B, Quesson B, Delalande C, Canioni P, Dousset V, Petry KG. (2000). In vivo evaluation of remyelination in rat brain by magnetisation transfer. J Neurol Sci, 178: 10-16.
12. Gonen O, Catalaa I, Babb JS, Ge Y, Mannon LJ, Kolson DL, Grossman RI. (2000). Total brain N-acetylaspartate: A new measure of disease load in MS. Neurology, 54: 15-19.
13. Kappos L, Moeri D, Radue EW, et al. (1999). Predictive value of gadoliniumenhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet, 353: 964-969.
14. Lycklama à Nijeholt GJ, Uitdehaag BM, Bergers E, Castelijns JA, Polman CH, Barkhof F. (2000). Spinal cord magnetic resonance imaging in suspected multiple sclerosis. European Radiol, 10: 368-376.
15. McDonald WI, Compston A, Edan G, et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol, 50: 121-127.
16. O'riordan JI, Losseff NA, Phatouros C, et al. (1998). Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem and spinal cord syndrome suggestive of demyelination. J Neurol Neurosurg Psychiat, 64: 353-357.
17. Paty DW, Oger JJ, Kastrukoff LF, et al. (1988). MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal bandind and CT. Neurology, 38: 180-185.
18. Rovaris M, Filippi M. (2000). MRI correlates of cognitive dysfunction in multiple sclerosis patients. J Neurovirol, 6 Suppl 2: S172-S175.
19. Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L. (1999). Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology, 53: 1698-1704.
20. Simon J. (2000). The contribution of spinal cord MRI to the diagnosis and differential diagnosis of multiple sclerosis. J Neurol Sci, 172 (suppltl): S32-S35.
21. Tintore M, Rovira A, Martinez MJ, et al. (2000). Isolated demyelinating syndromes: Comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol, 21: 702-706.
22. Thompson AJ, Polman CH, Miller DH, et al. (1997). Primary progressive multiple sclerosis. Brain, 120: 1085-1096.
23. Thompson AJ, Montalban X, Barkhof F, et al. (2000). Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Ann Neurol, 47: 831-835.
24. Thorpe JW, Kidd D, Moseley IF, et al. (1997). Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain, 119: 709-714.
25. Tourbah A, Stievenart JL, Gout O, et al. (1999). Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis. Neurology, 53: 1091-1097.
26. Tourbah A, Berry I pour le groupe d'étude de I'IRM dans la SEP coordonné par l'ARSEP. (2001). Recommandations pour la pratique de l'IRM dans la SEP. Rev Neurol (Paris), 157: 122-125.
27. Van Buchem MA, Udupa JK, McGowan JC, et al. (1997). Global volumetric estimation of disease burden in multiple sclerosis based on magnetization transfer imaging. AJNR Am J Neuroradiol, 18: 1287-1290.
28. Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. (1999). Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology, 52: 1626-1632.